Associations representing the European and the U.S. pharmaceutical industries July 24 jointly endorsed principles for responsible clinical trial data-sharing, adding to an issue that has been wracked with controversy.
“Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers” reflect strong support for sharing clinical trial data to benefit patients and foster scientific discovery in a way that maintains patient privacy, the integrity of regulatory systems, and incentives to invest in biomedical research, according to the announcement.
“We believe it is important to engage with all stakeholders in the clinical trial ecosystem, including the patients who volunteer to participate in clinical trials, about the issue.”
—Matt Bennett, PhRMA senior vice president
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.